857 related articles for article (PubMed ID: 25519222)
1. CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis.
Gidwani R; Bhattacharya J
J Gen Intern Med; 2015 May; 30(5):588-96. PubMed ID: 25519222
[TBL] [Abstract][Full Text] [Related]
2. Hospital charges associated with "never events": comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty.
Daniels AH; Kawaguchi S; Contag AG; Rastegar F; Waagmeester G; Anderson PA; Arthur M; Hart RA
J Neurosurg Spine; 2016 Aug; 25(2):165-9. PubMed ID: 26989978
[TBL] [Abstract][Full Text] [Related]
3. Capsule commentary on Gidwani et al., CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis.
Stoecker C
J Gen Intern Med; 2015 May; 30(5):651. PubMed ID: 25617164
[No Abstract] [Full Text] [Related]
4. Inpatient Consults and Complications During Primary Total Joint Arthroplasty in a Bundled Care Model.
Baumgartner BT; Karas V; Kildow BJ; Cunningham DJ; Klement MR; Green CL; Attarian DE; Seyler TM
J Arthroplasty; 2018 Apr; 33(4):973-975. PubMed ID: 29273289
[TBL] [Abstract][Full Text] [Related]
5. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study.
Sudo A; Sano T; Horikawa K; Yamakawa T; Shi D; Uchida A
J Orthop Surg (Hong Kong); 2003 Dec; 11(2):174-7. PubMed ID: 14676343
[TBL] [Abstract][Full Text] [Related]
6. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
8. Changing Patterns of Anticoagulation After Total Hip Arthroplasty in the United States: Frequency of Deep Vein Thrombosis, Pulmonary Embolism, and Complications With Rivaroxaban and Warfarin.
Glassberg MB; Lachiewicz PF
J Arthroplasty; 2019 Aug; 34(8):1793-1801. PubMed ID: 31005440
[TBL] [Abstract][Full Text] [Related]
9. Inpatient pulmonary embolism after elective primary total hip and knee arthroplasty in the United States.
Zahir U; Sterling RS; Pellegrini VD; Forte ML
J Bone Joint Surg Am; 2013 Nov; 95(22):e175. PubMed ID: 24257675
[TBL] [Abstract][Full Text] [Related]
10. CMS Reimbursement Reform.
Gidwani R; Bhattacharya J
J Gen Intern Med; 2015 Nov; 30(11):1588. PubMed ID: 26179821
[No Abstract] [Full Text] [Related]
11. CMS Reimbursement Reform.
Taylor SP; Ecker DJ; Taylor B
J Gen Intern Med; 2015 Nov; 30(11):1587. PubMed ID: 26163008
[No Abstract] [Full Text] [Related]
12. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Amin AN; Lin J; Thompson S; Wiederkehr D
Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
[TBL] [Abstract][Full Text] [Related]
13. Incidence of symptomatic venous thromboembolism after elective knee arthroscopy.
Maletis GB; Inacio MC; Reynolds S; Funahashi TT
J Bone Joint Surg Am; 2012 Apr; 94(8):714-20. PubMed ID: 22517387
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
[TBL] [Abstract][Full Text] [Related]
15. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
[TBL] [Abstract][Full Text] [Related]
16. Medicare Reimbursement for Total Joint Arthroplasty: The Driving Forces.
Padegimas EM; Verma K; Zmistowski B; Rothman RH; Purtill JJ; Howley M
J Bone Joint Surg Am; 2016 Jun; 98(12):1007-13. PubMed ID: 27307361
[TBL] [Abstract][Full Text] [Related]
17. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
18. Venous Thromboembolism Rates Did Not Decrease in Lower Extremity Revision Total Joint Arthroplasty From 2008 to 2016.
Warren JA; Sundaram K; Kamath AF; Molloy RM; Krebs VE; Mont MA; Piuzzi NS
J Arthroplasty; 2019 Nov; 34(11):2774-2779. PubMed ID: 31153709
[TBL] [Abstract][Full Text] [Related]
19. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2002 May; 96(5):1140-6. PubMed ID: 11981154
[TBL] [Abstract][Full Text] [Related]
20. Incidence of deep vein thrombosis after major lower limb orthopedic surgery: analysis of a nationwide claim registry.
Lee SY; Ro du H; Chung CY; Lee KM; Kwon SS; Sung KH; Park MS
Yonsei Med J; 2015 Jan; 56(1):139-45. PubMed ID: 25510757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
